메뉴 건너뛰기




Volumn 11, Issue 6, 2011, Pages 723-737

Gene therapy for ischemic heart disease

Author keywords

AAV; adenovirus; angiogenesis; contractility; gene therapy; ischemic heart disease; miRNA

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOVIRUS VECTOR; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; CALGRANULIN A; DOUBLE STRANDED DNA; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 5; G PROTEIN COUPLED RECEPTOR KINASE 2; INTERCELLULAR ADHESION MOLECULE 1; LENTIVIRUS VECTOR; MICRORNA; NAKED DNA; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN A; VASCULOTROPIN C; VIRUS PROTEIN;

EID: 79955871083     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2011.570749     Document Type: Review
Times cited : (49)

References (114)
  • 1
    • 77649126524 scopus 로고    scopus 로고
    • Heart disease and stroke statistics - 2010 update: A report from the American Heart Association
    • Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 2010;121:e46-215.
    • (2010) Circulation , vol.121
    • Lloyd-Jones, D.1    Adams, R.J.2    Brown, T.M.3
  • 2
    • 0034888004 scopus 로고    scopus 로고
    • Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: A 20-year experience
    • DOI 10.1016/S0735-1097(01)01349-3, PII S0735109701013493
    • Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol 2001;38:409-14. (Pubitemid 32721768)
    • (2001) Journal of the American College of Cardiology , vol.38 , Issue.2 , pp. 409-414
    • Suero, J.A.1    Marso, S.P.2    Jones, P.G.3    Laster, S.B.4    Huber, K.C.5    Giorgi, L.V.6    Johnson, W.L.7    Rutherford, B.D.8
  • 3
    • 49449104281 scopus 로고    scopus 로고
    • Acute myocardial infarction
    • White HD, Chew DP. Acute myocardial infarction. Lancet 2008;372:570-84.
    • (2008) Lancet , vol.372 , pp. 570-84
    • White, H.D.1    Chew, D.P.2
  • 4
    • 34548746306 scopus 로고    scopus 로고
    • Myocardial reperfusion injury
    • Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357:1121-35.
    • (2007) N Engl J Med , vol.357 , pp. 1121-35
    • Yellon, D.M.1    Hausenloy, D.J.2
  • 7
    • 38349006586 scopus 로고    scopus 로고
    • Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: Findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial
    • Pedrazzini G, Santoro E, Latini R, et al. Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial. Am Heart J 2008;155:388-94.
    • (2008) Am Heart J , vol.155 , pp. 388-94
    • Pedrazzini, G.1    Santoro, E.2    Latini, R.3
  • 9
    • 55949108787 scopus 로고    scopus 로고
    • Designing heart performance by gene transfer
    • Davis J, Westfall MV, Townsend D, et al. Designing heart performance by gene transfer. Physiol Rev 2008;88:1567-651.
    • (2008) Physiol Rev , vol.88 , pp. 1567-651
    • Davis, J.1    Westfall, M.V.2    Townsend, D.3
  • 10
    • 0037188561 scopus 로고    scopus 로고
    • Myocardial regeneration therapy for heart failure: Hepatocyte growth factor enhances the effect of cellular cardiomyoplasty
    • DOI 10.1161/01.CIR.0000016722.37138.F2
    • Miyagawa S, Sawa Y, Taketani S, et al. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 2002;105:2556-61. (Pubitemid 34568980)
    • (2002) Circulation , vol.105 , Issue.21 , pp. 2556-2561
    • Miyagawa, S.1    Sawa, Y.2    Taketani, S.3    Kawaguchi, N.4    Nakamura, T.5    Matsuura, N.6    Matsuda, H.7
  • 11
    • 0041876318 scopus 로고    scopus 로고
    • Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer
    • DOI 10.1038/sj.gt.3302034
    • Lee M, Rentz J, Bikram M, et al. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther 2003;10:1535-42. (Pubitemid 37063258)
    • (2003) Gene Therapy , vol.10 , Issue.18 , pp. 1535-1542
    • Lee, M.1    Rentz, J.2    Bikram, M.3    Han, S.4    Bull, D.A.5    Kim, S.W.6
  • 13
    • 16544377151 scopus 로고    scopus 로고
    • Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer
    • Pitard B, Bello-Roufai M, Lambert O, et al. Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer. Nucleic Acids Res 2004;32:e159
    • (2004) Nucleic Acids Res , vol.32
    • Pitard, B.1    Bello-Roufai, M.2    Lambert, O.3
  • 14
    • 0035078206 scopus 로고    scopus 로고
    • Augmentation of myocardial transfection using TerplexDNA: A novel gene delivery system
    • DOI 10.1038/sj.gt.3301395
    • Affleck DG, Yu L, Bull DA, et al. Augmentation of myocardial transfection using TerplexDNA: a novel gene delivery system. Gene Ther 2001;8:349-53. (Pubitemid 32241934)
    • (2001) Gene Therapy , vol.8 , Issue.5 , pp. 349-353
    • Affleck, D.G.1    Yu, L.2    Bull, D.A.3    Bailey, S.H.4    Kim, S.W.5
  • 15
    • 76849097642 scopus 로고    scopus 로고
    • Nonviral intercellular adhesion molecule-1 small interfering ribonucleic acid sequences transfection in vivo how ultrasound bursts into therapy
    • Kupatt C. Nonviral intercellular adhesion molecule-1 small interfering ribonucleic acid sequences transfection in vivo how ultrasound bursts into therapy. J Am Coll Cardiol 2010;55:914-16.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 914-16
    • Kupatt, C.1
  • 17
    • 77951956539 scopus 로고    scopus 로고
    • Cellular endocytosis and gene delivery
    • Ziello JE, Huang Y, Jovin IS. Cellular endocytosis and gene delivery. Mol Med 2010;16:222-9.
    • (2010) Mol Med , vol.16 , pp. 222-9
    • Ziello, J.E.1    Huang, Y.2    Jovin, I.S.3
  • 18
    • 0038745599 scopus 로고    scopus 로고
    • Progress and problems with the use of viral vectors for gene therapy
    • DOI 10.1038/nrg1066
    • Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4:346-58. (Pubitemid 36538359)
    • (2003) Nature Reviews Genetics , vol.4 , Issue.5 , pp. 346-358
    • Thomas, C.E.1    Ehrhardt, A.2    Kay, M.A.3
  • 20
    • 27544511553 scopus 로고    scopus 로고
    • Gutted adenovirus: A rising star on the horizon?
    • DOI 10.1038/sj.gt.3302597, PII 3302597
    • Ehrhardt A, Kay MA. Gutted adenovirus: a rising star on the horizon? Gene Ther 2005;12:1540-1. (Pubitemid 41541770)
    • (2005) Gene Therapy , vol.12 , Issue.21 , pp. 1540-1541
    • Ehrhardt, A.1    Kay, M.A.2
  • 21
    • 11144248909 scopus 로고    scopus 로고
    • The innate immune response to adenovirus vectors
    • Muruve DA. The innate immune response to adenovirus vectors. Hum Gene Ther 2004;15:1157-66. (Pubitemid 40052429)
    • (2004) Human Gene Therapy , vol.15 , Issue.12 , pp. 1157-1166
    • Muruve, D.A.1
  • 26
    • 0036341380 scopus 로고    scopus 로고
    • Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery
    • Hoshijima M, Ikeda Y, Iwanaga Y, et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 2002;8:864-71.
    • (2002) Nat Med , vol.8 , pp. 864-71
    • Hoshijima, M.1    Ikeda, Y.2    Iwanaga, Y.3
  • 27
    • 37749013444 scopus 로고    scopus 로고
    • Gene therapy: Targeting the myocardium
    • Lyon AR, Sato M, Hajjar RJ, et al. Gene therapy: targeting the myocardium. Heart 2008;94:89-99.
    • (2008) Heart , vol.94 , pp. 89-99
    • Lyon, A.R.1    Sato, M.2    Hajjar, R.J.3
  • 29
    • 62649151797 scopus 로고    scopus 로고
    • A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
    • Yang L, Jiang JG, Drouin LM, et al. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection. Proc Natl Acad Sci USA 2009;106:3946-51.
    • (2009) Proc Natl Acad Sci USA , vol.106 , pp. 3946-51
    • Yang, L.1    Jiang, J.G.2    Drouin, L.M.3
  • 30
    • 74049120342 scopus 로고    scopus 로고
    • Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle
    • Asokan A, Conway JC, Phillips JL, et al. Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nat Biotech 2010;28:79-82.
    • (2010) Nat Biotech , vol.28 , pp. 79-82
    • Asokan, A.1    Conway, J.C.2    Phillips, J.L.3
  • 31
    • 65249108107 scopus 로고    scopus 로고
    • Preventing and exploiting the oncogenic potential of integrating gene vectors
    • Modlich U, Baum C. Preventing and exploiting the oncogenic potential of integrating gene vectors. J Clin Invest 2009;119:755-8.
    • (2009) J Clin Invest , vol.119 , pp. 755-8
    • Modlich, U.1    Baum, C.2
  • 32
    • 65249101260 scopus 로고    scopus 로고
    • The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
    • Montini E, Cesana D, Schmidt M, et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 2009;119:964-75.
    • (2009) J Clin Invest , vol.119 , pp. 964-75
    • Montini, E.1    Cesana, D.2    Schmidt, M.3
  • 33
    • 0032553469 scopus 로고    scopus 로고
    • Gene therapy Treating with HIV
    • Sikorski R, Peters R. Gene therapy. Treating with HIV. Science 1998;282:1438.
    • (1998) Science , vol.282 , pp. 1438
    • Sikorski, R.1    Peters, R.2
  • 34
    • 0033618547 scopus 로고    scopus 로고
    • Lentiviral vectors - The promise of gene therapy within reach?
    • Amado RG, Chen IS. Lentiviral vectors - the promise of gene therapy within reach? Science 1999;285:674-6.
    • (1999) Science , vol.285 , pp. 674-6
    • Amado, R.G.1    Chen, I.S.2
  • 36
    • 33646241297 scopus 로고    scopus 로고
    • Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro
    • Simmons A, Whitehead RP, Kolokoltsov AA, Davey RA. Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro. Virol J 2006;3:8
    • (2006) Virol J , vol.3 , pp. 8
    • Simmons, A.1    Whitehead, R.P.2    Kolokoltsov, A.A.3    Davey, R.A.4
  • 37
    • 0036732734 scopus 로고    scopus 로고
    • Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo
    • Zhao J, Pettigrew GJ, Thomas J, et al. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol 2002;97:348-58.
    • (2002) Basic Res Cardiol , vol.97 , pp. 348-58
    • Zhao, J.1    Pettigrew, G.J.2    Thomas, J.3
  • 38
    • 0038663005 scopus 로고    scopus 로고
    • Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo
    • DOI 10.1161/01.CIR.0000065598.46411.EF
    • Fleury S, Simeoni E, Zuppinger C, et al. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo. Circulation 2003;107:2375-82. (Pubitemid 36578511)
    • (2003) Circulation , vol.107 , Issue.18 , pp. 2375-2382
    • Fleury, S.1    Simeoni, E.2    Zuppinger, C.3    Deglon, N.4    Von Segesser, L.K.5    Kappenberger, L.6    Vassalli, G.7
  • 39
    • 0035135747 scopus 로고    scopus 로고
    • Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics
    • DOI 10.1038/83324
    • Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001;7:33-40. (Pubitemid 32095639)
    • (2001) Nature Medicine , vol.7 , Issue.1 , pp. 33-40
    • Kay, M.A.1    Glorioso, J.C.2    Naldini, L.3
  • 42
    • 25444463573 scopus 로고    scopus 로고
    • Endothelial/pericyte interactions
    • DOI 10.1161/01.RES.0000182903.16652.d7
    • Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005;97:512-23. (Pubitemid 41361741)
    • (2005) Circulation Research , vol.97 , Issue.6 , pp. 512-523
    • Armulik, A.1    Abramsson, A.2    Betsholtz, C.3
  • 44
    • 0037197740 scopus 로고    scopus 로고
    • Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia
    • DOI 10.1161/01.CIR.0000015982.70785.B7
    • Losordo DW, Vale PR, Hendel RC, et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002;105:2012-18. (Pubitemid 34465261)
    • (2002) Circulation , vol.105 , Issue.17 , pp. 2012-2018
    • Losordo, D.W.1    Vale, P.R.2    Hendel, R.C.3    Milliken, C.E.4    Fortuin, F.D.5    Cummings, N.6    Schatz, R.A.7    Asahara, T.8    Isner, J.M.9    Kuntz, R.E.10
  • 45
    • 67349287066 scopus 로고    scopus 로고
    • VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: Results of the NORTHERN trial
    • Stewart DJ, Kutryk MJB, Fitchett D, et al. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol Ther 2009;17:1109-15.
    • (2009) Mol Ther , vol.17 , pp. 1109-15
    • Stewart, D.J.1    Mjb, K.2    Fitchett, D.3
  • 48
    • 79954490234 scopus 로고    scopus 로고
    • A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: The NOVA trial
    • Kastrup J, Jorgensen E, Fuchs S, et al. A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial. EuroIntervention 2011;6:813-18.
    • (2011) EuroIntervention , vol.6 , pp. 813-18
    • Kastrup, J.1    Jorgensen, E.2    Fuchs, S.3
  • 49
    • 33747488429 scopus 로고    scopus 로고
    • An update on angiogenic gene therapy: Vascular endothelial growth factor and other directions
    • Yla-Herttuala S. An update on angiogenic gene therapy: vascular endothelial growth factor and other directions. Curr Opin Mol Ther 2006;8:295-300. (Pubitemid 44256363)
    • (2006) Current Opinion in Molecular Therapeutics , vol.8 , Issue.4 , pp. 295-300
    • Yla-Herttuala, S.1
  • 50
    • 0036789313 scopus 로고    scopus 로고
    • The role of fibroblast growth factors in vascular development
    • Javerzat S, Auguste P, Bikfalvi A. The role of fibroblast growth factors in vascular development. Trends Mol Med 2002;8:483-9.
    • (2002) Trends Mol Med , vol.8 , pp. 483-9
    • Javerzat, S.1    Auguste, P.2    Bikfalvi, A.3
  • 52
    • 0242459072 scopus 로고    scopus 로고
    • Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): A new option for the treatment of coronary artery disease
    • DOI 10.1016/S0002-9149(03)00965-2
    • Grines C, Rubanyi GM, Kleiman NS, et al. Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease. Am J Cardiol 2003;92:24N-31N. (Pubitemid 37412348)
    • (2003) American Journal of Cardiology , vol.92 , Issue.9 SUPPL. 2
    • Grines, C.1    Rubanyi, G.M.2    Kleiman, N.S.3    Marrott, P.4    Watkins, M.W.5
  • 55
    • 0032889971 scopus 로고    scopus 로고
    • Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development
    • Carmeliet P, Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Top Microbiol Immunol 1999;237:133-58. (Pubitemid 28554862)
    • (1999) Current Topics in Microbiology and Immunology , vol.237 , pp. 133-158
    • Carmeliet, P.1    Collen, D.2
  • 57
    • 77955285388 scopus 로고    scopus 로고
    • Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion: Role of vessel maturation
    • Kupatt C, Hinkel R, Pfosser A, et al. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion: role of vessel maturation. JACC 2010;56:414-22.
    • (2010) JACC , vol.56 , pp. 414-22
    • Kupatt, C.1    Hinkel, R.2    Pfosser, A.3
  • 58
    • 78649455280 scopus 로고    scopus 로고
    • Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization
    • Stratman AN, Schwindt AE, Malotte KM, Davis GE. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 2010;116:4720-30
    • (2010) Blood , vol.116 , pp. 4720-30
    • Stratman, A.N.1    Schwindt, A.E.2    Malotte, K.M.3    Davis, G.E.4
  • 61
    • 57949098602 scopus 로고    scopus 로고
    • Collateral circulation past and present
    • Schaper W. Collateral circulation past and present. Basic Res Cardiol 2009;104:5-21.
    • (2009) Basic Res Cardiol , vol.104 , pp. 5-21
    • Schaper, W.1
  • 62
    • 62149099949 scopus 로고    scopus 로고
    • Stimulation of collateral artery growth: Travelling further down the road to clinical application
    • Schirmer SH, van Nooijen FC, Piek JJ, van Royen N. Stimulation of collateral artery growth: travelling further down the road to clinical application. Heart 2009;95:191-7.
    • (2009) Heart , vol.95 , pp. 191-7
    • Schirmer, S.H.1    Van Nooijen, F.C.2    Piek, J.J.3    Van Royen, N.4
  • 63
    • 27444435410 scopus 로고    scopus 로고
    • Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease
    • DOI 10.1016/j.jacc.2005.01.068, PII S0735109705018395
    • Zbinden S, Zbinden R, Meier P, et al. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1636-42. (Pubitemid 41531615)
    • (2005) Journal of the American College of Cardiology , vol.46 , Issue.9 , pp. 1636-1642
    • Zbinden, S.1    Zbinden, R.2    Meier, P.3    Windecker, S.4    Seiler, C.5
  • 65
    • 0037599451 scopus 로고    scopus 로고
    • Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients
    • DOI 10.1054/jcaf.2003.28
    • Jaski BE, Ha J, Denys BG, et al. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 2003;9:227-31. (Pubitemid 36734320)
    • (2003) Journal of Cardiac Failure , vol.9 , Issue.3 , pp. 227-231
    • Jaski, B.E.1    Ha, J.2    Denys, B.G.3    Lamba, S.4    Trupp, R.J.5    Abraham, W.T.6
  • 71
    • 77949419010 scopus 로고    scopus 로고
    • Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction
    • Sumida A, Horiba M, Ishiguro H, et al. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Cardiovasc Res 2010;86:113-21.
    • (2010) Cardiovasc Res , vol.86 , pp. 113-21
    • Sumida, A.1    Horiba, M.2    Ishiguro, H.3
  • 72
    • 77649253288 scopus 로고    scopus 로고
    • MicroRNAs add a new dimension to cardiovascular disease
    • Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010;121:1022-32.
    • (2010) Circulation , vol.121 , pp. 1022-32
    • Small, E.M.1    Frost, R.J.2    Olson, E.N.3
  • 73
    • 77952349351 scopus 로고    scopus 로고
    • Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure
    • Poller W, Hajjar R, Schultheiss HP, Fechner H. Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure. Cardiovasc Res 2010;86:353-64.
    • (2010) Cardiovasc Res , vol.86 , pp. 353-64
    • Poller, W.1    Hajjar, R.2    Schultheiss, H.P.3    Fechner, H.4
  • 74
    • 78149355643 scopus 로고    scopus 로고
    • "locked onto the target": Increasing the efficiency of antagomirzymes using locked nucleic acid modifications
    • Kaur H, Scaria V, Maiti S. "Locked onto the target": increasing the efficiency of antagomirzymes using locked nucleic acid modifications. Biochemistry 2010;49:9449-56
    • (2010) Biochemistry , vol.49 , pp. 9449-56
    • Kaur, H.1    Scaria, V.2    Maiti, S.3
  • 75
    • 55249123349 scopus 로고    scopus 로고
    • Cardiac dissonance without conductors: How dicer depletion provokes chaos in the heart
    • Thum T. Cardiac dissonance without conductors: how dicer depletion provokes chaos in the heart. Circulation 2008;118:1524-7.
    • (2008) Circulation , vol.118 , pp. 1524-7
    • Thum, T.1
  • 76
    • 70349254444 scopus 로고    scopus 로고
    • Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure
    • Rao PK, Toyama Y, Chiang HR, et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 2009;105:585-94.
    • (2009) Circ Res , vol.105 , pp. 585-94
    • Rao, P.K.1    Toyama, Y.2    Chiang, H.R.3
  • 77
    • 34247589595 scopus 로고    scopus 로고
    • Control of stress-dependent cardiac growth and gene expression by a microRNA
    • DOI 10.1126/science.1139089
    • van Rooij E, Sutherland LB, Qi XX, et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007;316:575-9. (Pubitemid 46683138)
    • (2007) Science , vol.316 , Issue.5824 , pp. 575-579
    • Van Rooij, E.1    Sutherland, L.B.2    Qi, X.3    Richardson, J.A.4    Hill, J.5    Olson, E.N.6
  • 78
    • 70349202176 scopus 로고    scopus 로고
    • MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice
    • Callis TE, Pandya K, Seok HY, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009;119:2772-86.
    • (2009) J Clin Invest , vol.119 , pp. 2772-86
    • Callis, T.E.1    Pandya, K.2    Seok, H.Y.3
  • 79
    • 57749168828 scopus 로고    scopus 로고
    • MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
    • Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-4.
    • (2008) Nature , vol.456 , pp. 980-4
    • Thum, T.1    Gross, C.2    Fiedler, J.3
  • 80
    • 78049432896 scopus 로고    scopus 로고
    • Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice
    • Patrick DM, Montgomery RL, Qi X, et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 2010;120:3912-6.
    • (2010) J Clin Invest , vol.120 , pp. 3912-6
    • Patrick, D.M.1    Montgomery, R.L.2    Qi, X.3
  • 81
    • 48849095818 scopus 로고    scopus 로고
    • MiRNA expression in the failing human heart: Functional correlates
    • Sucharov C, Bristow MR, Port JD. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol 2008;45:185-92.
    • (2008) J Mol Cell Cardiol , vol.45 , pp. 185-92
    • Sucharov, C.1    Bristow, M.R.2    Port, J.D.3
  • 82
    • 73449086958 scopus 로고    scopus 로고
    • Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions
    • Elia L, Contu R, Quintavalle M, et al. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 2009;120:2377-85.
    • (2009) Circulation , vol.120 , pp. 2377-85
    • Elia, L.1    Contu, R.2    Quintavalle, M.3
  • 84
    • 22444437609 scopus 로고    scopus 로고
    • Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis
    • DOI 10.1038/nature03817
    • Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005;436:214-20. (Pubitemid 41021266)
    • (2005) Nature , vol.436 , Issue.7048 , pp. 214-220
    • Zhao, Y.1    Samal, E.2    Srivastava, D.3
  • 85
    • 34948829119 scopus 로고    scopus 로고
    • The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes
    • DOI 10.1242/jcs.010728
    • Xu C, Lu Y, Pan Z, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007;120:3045-52. (Pubitemid 47517087)
    • (2007) Journal of Cell Science , vol.120 , Issue.17 , pp. 3045-3052
    • Xu, C.1    Lu, Y.2    Pan, Z.3    Chu, W.4    Luo, X.5    Lin, H.6    Xiao, J.7    Shan, H.8    Wang, Z.9    Yang, B.10
  • 87
    • 65249185780 scopus 로고    scopus 로고
    • Downregulation of MiR-199a derepresses hypoxia-inducible factor-1 alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes
    • Rane S, He MZ, Sayed D, et al. Downregulation of MiR-199a derepresses hypoxia-inducible factor-1 alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 2009;104:879-86.
    • (2009) Circ Res , vol.104 , pp. 879-86
    • Rane, S.1    He, M.Z.2    Sayed, D.3
  • 88
    • 66349123063 scopus 로고    scopus 로고
    • MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20
    • Ren XP, Wu JH, Wang XH, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009;119:2357-66.
    • (2009) Circulation , vol.119 , pp. 2357-66
    • Ren, X.P.1    Wu, J.H.2    Wang, X.H.3
  • 89
    • 33751173635 scopus 로고    scopus 로고
    • MicroRNAs modulate the angiogenic properties of HLTVECs
    • Poliseno L, Tuccoli A, Mariani L, et al. MicroRNAs modulate the angiogenic properties of HLTVECs. Blood 2006;108:3068-71.
    • (2006) Blood , vol.108 , pp. 3068-71
    • Poliseno, L.1    Tuccoli, A.2    Mariani, L.3
  • 90
    • 45549086958 scopus 로고    scopus 로고
    • Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210
    • Pulkkinen K, Malm T, Turunen M, et al. Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett 2008;582:2397-401.
    • (2008) FEBS Lett , vol.582 , pp. 2397-401
    • Pulkkinen, K.1    Malm, T.2    Turunen, M.3
  • 91
    • 48749130187 scopus 로고    scopus 로고
    • MiR-126 regulates angiogenic signaling and vascular integrity
    • Fish JE, Santoro MM, Morton SU, et al. MiR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008;15:272-84.
    • (2008) Dev Cell , vol.15 , pp. 272-84
    • Fish, J.E.1    Santoro, M.M.2    Morton, S.U.3
  • 92
    • 67649998366 scopus 로고    scopus 로고
    • MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice
    • Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009;324:1710-13.
    • (2009) Science , vol.324 , pp. 1710-13
    • Bonauer, A.1    Carmona, G.2    Iwasaki, M.3
  • 94
    • 44349170706 scopus 로고    scopus 로고
    • Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection
    • DOI 10.1038/mt.2008.76, PII MT200876
    • Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 2008;16:1073-80. (Pubitemid 351737072)
    • (2008) Molecular Therapy , vol.16 , Issue.6 , pp. 1073-1080
    • Zincarelli, C.1    Soltys, S.2    Rengo, G.3    Rabinowitz, J.E.4
  • 96
    • 1142285445 scopus 로고    scopus 로고
    • Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model
    • DOI 10.1016/j.cardiores.2003.11.012
    • Kupatt C, Hinkel R, Horstkotte J, et al. Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model. Cardiovasc Res 2004;61:530-7. (Pubitemid 38210158)
    • (2004) Cardiovascular Research , vol.61 , Issue.3 , pp. 530-537
    • Kupatt, C.1    Hinkel, R.2    Horstkotte, J.3    Deiss, M.4    Von Bruhl, M.-L.5    Bilzer, M.6    Boekstegers, P.7
  • 98
    • 78650979325 scopus 로고    scopus 로고
    • Robust cardiomyocyte-specific gene expression following systemic injection of AAV: In vivo gene delivery follows a Poisson distribution
    • Prasad KM, Xu Y, Yang Z, et al. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther 2011;18:43-52.
    • (2011) Gene Ther , vol.18 , pp. 43-52
    • Prasad, K.M.1    Xu, Y.2    Yang, Z.3
  • 99
    • 48749117919 scopus 로고    scopus 로고
    • Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route
    • Baldazzi F, Jorgensen E, Ripa RS, Kastrup J. Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route. Eur Heart J 2008;29:1819-26.
    • (2008) Eur Heart J , vol.29 , pp. 1819-26
    • Baldazzi, F.1    Jorgensen, E.2    Ripa, R.S.3    Kastrup, J.4
  • 100
    • 77950962141 scopus 로고    scopus 로고
    • Cardiac gene therapy: Optimization of gene delivery techniques in vivo
    • Katz MG, Swain JD, White JD, et al. Cardiac gene therapy: optimization of gene delivery techniques in vivo. Hum Gene Ther 2010;21:371-80.
    • (2010) Hum Gene Ther , vol.21 , pp. 371-80
    • Katz, M.G.1    Swain, J.D.2    White, J.D.3
  • 101
    • 77951738011 scopus 로고    scopus 로고
    • Myocardial transfection of hypoxia inducible factor-1alpha via an adenoviral vector during coronary artery bypass grafting - A multicenter Phase i and safety study
    • Kilian EG, Sadoni S, Vicol C, et al. Myocardial transfection of hypoxia inducible factor-1alpha via an adenoviral vector during coronary artery bypass grafting - a multicenter Phase I and safety study. Circ J 2010;74:916-24.
    • (2010) Circ J , vol.74 , pp. 916-24
    • Kilian, E.G.1    Sadoni, S.2    Vicol, C.3
  • 103
    • 0027944524 scopus 로고
    • Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors
    • French BA, Mazur W, Geske RS, Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 1994;90:2414-24.
    • (1994) Circulation , vol.90 , pp. 2414-24
    • French, B.A.1    Mazur, W.2    Geske, R.S.3    Bolli, R.4
  • 104
    • 0042856409 scopus 로고    scopus 로고
    • Catheter-based intracoronary myocardial adenoviral gene delivery: Importance of intraluminal seal and infusion flow rate
    • DOI 10.1016/S1525-0016(03)00149-7
    • Emani SM, Shah AS, Bowman MK, et al. Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. Mol Ther 2003;8:306-13. (Pubitemid 37062840)
    • (2003) Molecular Therapy , vol.8 , Issue.2 , pp. 306-313
    • Emani, S.M.1    Shah, A.S.2    Bowman, M.K.3    Emani, S.4    Wilson, K.5    Glower, D.D.6    Koch, W.J.7
  • 105
    • 77955516095 scopus 로고    scopus 로고
    • Delivery of gene and cellular therapies for heart disease
    • Mariani JA, Kaye DM. Delivery of gene and cellular therapies for heart disease. J Cardiovasc Transl Res 2010;3:417-26.
    • (2010) J Cardiovasc Transl Res , vol.3 , pp. 417-26
    • Mariani, J.A.1    Kaye, D.M.2
  • 107
    • 0034619585 scopus 로고    scopus 로고
    • Intracoronary delivery of adenovirus encoding adenylyl cyclase VT increases left ventricular function and cAMP-generating capacity
    • Lai NC, Roth DM, Gao MH, et al. Intracoronary delivery of adenovirus encoding adenylyl cyclase VT increases left ventricular function and cAMP-generating capacity. Circulation 2000;102:2396-401.
    • (2000) Circulation , vol.102 , pp. 2396-401
    • Lai, N.C.1    Roth, D.M.2    Gao, M.H.3
  • 109
    • 7744222434 scopus 로고    scopus 로고
    • Current concepts and applications of coronary venous retroinfusion
    • DOI 10.1007/s00395-004-0486-3
    • Boekstegers P, Kupatt C. Current concepts and applications of coronary venous retroinfusion. Basic Res Cardiol 2004;99:373-81. (Pubitemid 39462359)
    • (2004) Basic Research in Cardiology , vol.99 , Issue.6 , pp. 373-381
    • Boekstegers, P.1    Kupatt, C.2
  • 110
    • 33846155891 scopus 로고    scopus 로고
    • Targeting the heart with gene therapy-optimized gene delivery methods
    • DOI 10.1016/j.cardiores.2006.09.021, PII S0008636306004378
    • Muller OJ, Katus HA, Bekeredjian R. Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res 2007;73:453-62. (Pubitemid 46084926)
    • (2007) Cardiovascular Research , vol.73 , Issue.3 , pp. 453-462
    • Muller, O.J.1    Katus, H.A.2    Bekeredjian, R.3
  • 113
    • 3943054801 scopus 로고    scopus 로고
    • Heat shock protein 90 transfection reduces ischemia-reperfusion - Induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation
    • DOI 10.1161/01.ATV.0000134300.87476.d1
    • Kupatt C, Dessy C, Hinkel R, et al. Heat shock protein 90 transfection reduces ischemia-reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation. Arterioscler Thromb Vasc Biol 2004;24:1435-41. (Pubitemid 39050437)
    • (2004) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.24 , Issue.8 , pp. 1435-1441
    • Kupatt, C.1    Dessy, C.2    Hinkel, R.3    Raake, P.4    Daneau, G.5    Bouzin, C.6    Boekstegers, P.7    Feron, O.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.